Format

Send to

Choose Destination
JAAD Case Rep. 2019 Feb 12;5(3):228-230. doi: 10.1016/j.jdcr.2019.01.003. eCollection 2019 Mar.

A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation.

Author information

1
The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
2
Department of Medicine, Division of Hematology, New York University School of Medicine, New York, New York.
3
Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, New York.

KEYWORDS:

CyBorD, cyclophosphamide, bortezomib, and dexamethasone; POEMS syndrome; POEMS, polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes; SDH, spontaneous subdural hemorrhage; VEGF, vascular endothelial growth factor; and skin changes; autologous stem cell transplantation; chemotherapy; endocrinopathy; monoclonal gammopathy; polyneuropathy organomegaly

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center